The Domnisol Budget Impact Model (BIM) is designed to provide medicines managers, budget holders and payors with fiscal responsibility, information and insight into the Prescription Only Medicines (POM) vitamin D market.
If you would like further information on how Domnisol may positively impact your local healthcare budget, please contact Flynn Pharma on support@flynnpharma.com.
ANY TREATMENT DECISIONS INVOLVING A MEDICINE OR SUBSEQUENT INTERVENTION SHOULD BE MADE AT THE DISCRETION OF THE TREATING PHYSICIAN BASED ON PATIENT RISK/BENEFIT. THE RELEVANT SUMMARY OF PRODUCT CHARACTERISTICS SHOULD BE CONSULTED BEFORE MAKING ANY PRESCRIBING DECISIONS.
- Domnisol 266 micrograms soft capsules – SmPC (accessed October 2024)
